Nex-I, Inc.
- Biotech or pharma, therapeutic R&D

NEX-I is an emerging company with groundbreaking ideas to propose next-gen immuno-oncology technology introducing a new paradigm in cancer therapy with a series of new target ONCOKINE(on smrt 이야기할것), that induces cancer cells to become resistant to the current therapy.